'Unethical behaviour' spoils drug giants' good work for the poor
London
THE world's top drugmakers have improved access to medicines in developing countries, according to a report, but their good work is undermined by a sorry record of unethical behaviour. The Access to Medicines Index, which ranks the 20 leading pharmaceutical companies every two years on how well they get treatments to the poor, said the industry's progress had been "uneven".
Eighteen of the firms monitored were the subject of settlements or fines for corrupt behaviour, unethical marketing or breaches of competition law in the last two years.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Billionaire Geiger is said to near US$7 billion L’Occitane buyout
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years